MGM Cancer Institute & MGM Healthcare Malar Save Two Elderly Cancer Patients with Advanced CAR-T Cell Therapy
Chennai, March 3, 2026: Strengthening their position as Centres of Excellence in Precision Oncology, MGM Cancer Institute and MGM Healthcare Malar have successfully administered Chimeric Antigen Receptor T-Cell (CAR-T) Therapy — a next-generation, cell-based immunotherapy — saving the lives of two elderly patients with aggressive cancers after conventional treatments had failed. (L to R) Dr. Suman Kalyan N, Senior Consultant – Medical Oncology and Director, CAR-T Program at MGM Healthcare Malar, Adyar; Dr. M.A. Raja, Director and Senior Consultant, Medical Oncology, MGM Cancer Institute; Dr. M. Gopinathan, Consultant – Hemato-Oncology (BMT), MGM Cancer Institute A breakthrough in personalised cancer care, CAR-T therapy involves engineering a patient’s own immune cells to identify and eliminate cancer cells. The therapy offers renewed hope for patients with advanced or relapsed cancers that no longer respond to standard chemotherapy. Press meet Youtube Video link ЁЯСЗ...